H.R. 5526 · 119th Congress (2025–2027)
Biosimilar Red Tape Elimination Act
To improve the requirements for making a determination of interchangeability of a biological product and its reference product.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 5526’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. August Pfluger (R-TX-11)
- Cosponsors
10 cosponsors
1 original · 9 later
6 R · 4 D
- Rep. Greg Landsman (D-OH-1)· Original · Sep 19, 2025
- Rep. Jake Auchincloss (D-MA-4)· Later · Oct 17, 2025
- Rep. Dan Crenshaw (R-TX-2)· Later · Nov 10, 2025
- Rep. Gabe Vasquez (D-NM-2)· Later · Dec 9, 2025
- Rep. Burgess Owens (R-UT-4)· Later · Feb 4, 2026
- Rep. Randy Fine (R-FL-6)· Later · Mar 9, 2026
- Rep. Blake D. Moore (R-UT-1)· Later · May 21, 2026
- Rep. Eric Sorensen (D-IL-17)· Later · Jun 4, 2026
- Rep. Craig A. Goldman (R-TX-12)· Later · Jul 15, 2026
- Rep. Robert J. Wittman (R-VA-1)· Later · Jul 21, 2026
- Policy area
- Health
- Subjects
- Drug safety, medical device, and laboratory regulation
- Government information and archives
- Licensing and registrations
- Prescription drugs
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Committees
Jul 20, 2026 · Markup
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Biosimilar Red Tape Elimination Act
Display title, Short title · Introduced in House
To improve the requirements for making a determination of interchangeability of a biological product and its reference product.
Official title · Introduced in House